Annual Interest Expense
$767.00 K
-$2.23 M-74.44%
31 December 2023
Summary:
Arcturus Therapeutics Holdings annual interest expense is currently $767.00 thousand, with the most recent change of -$2.23 million (-74.44%) on 31 December 2023. During the last 3 years, it has fallen by -$64.00 thousand (-7.70%). ARCT annual interest expense is now -74.44% below its all-time high of $3.00 million, reached on 31 December 2022.ARCT Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
N/A
30 September 2024
Summary:
Arcturus Therapeutics Holdings quarterly interest expense is not available.ARCT Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
N/A
30 September 2024
Summary:
Arcturus Therapeutics Holdings TTM interest expense is not available.ARCT TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARCT Interest Expense Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -74.4% | - | - |
3 y3 years | -7.7% | - | - |
5 y5 years | +312.4% | - | - |
ARCT Interest Expense High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -74.4% | at low | ||||
5 y | 5 years | -74.4% | +312.4% | ||||
alltime | all time | -74.4% | >+9999.0% |
Arcturus Therapeutics Holdings Interest Expense History
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2024 | - | $0.00(0.0%) | $0.00(-100.0%) |
Dec 2023 | $767.00 K(-74.4%) | - | - |
June 2023 | - | $0.00(-100.0%) | $2.30 M(-24.1%) |
Mar 2023 | - | $743.00 K(-5.9%) | $3.03 M(+0.8%) |
Dec 2022 | $3.00 M(+261.1%) | $790.00 K(+3.3%) | $3.00 M(+35.7%) |
Sept 2022 | - | $765.00 K(+5.1%) | $2.21 M(+2.5%) |
June 2022 | - | $728.00 K(+1.4%) | $2.16 M(+0.8%) |
Mar 2022 | - | $718.00 K(+1.0%) | $2.14 M(-0.9%) |
Sept 2021 | - | $711.00 K(+0.1%) | $2.16 M(+31.8%) |
June 2021 | - | $710.00 K(+30.0%) | $1.64 M(+45.9%) |
Mar 2021 | - | $546.00 K(+185.9%) | $1.12 M(+35.2%) |
Dec 2020 | $831.00 K(-2.7%) | $191.00 K(+0.5%) | $830.00 K(-5.6%) |
Sept 2020 | - | $190.00 K(-2.6%) | $879.00 K(-1.7%) |
June 2020 | - | $195.00 K(-23.2%) | $894.00 K(-1.2%) |
Mar 2020 | - | $254.00 K(+5.8%) | $905.00 K(+6.0%) |
Dec 2019 | $854.00 K(+359.1%) | $240.00 K(+17.1%) | $854.00 K(+7.0%) |
Sept 2019 | - | $205.00 K(-0.5%) | $798.00 K(+34.6%) |
June 2019 | - | $206.00 K(+1.5%) | $593.00 K(+172.0%) |
Mar 2019 | - | $203.00 K(+10.3%) | $218.00 K(+1353.3%) |
Dec 2018 | $186.00 K(+24.0%) | $184.00 K(-208.9%) | $15.00 K(-128.8%) |
June 2018 | - | -$169.00 K(<-9900.0%) | -$52.00 K(-134.7%) |
Mar 2018 | - | $0.00(-100.0%) | $150.00 K(+500.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2017 | $150.00 K(-49.2%) | $53.00 K(-17.2%) | $25.00 K(-96.6%) |
Sept 2017 | - | $64.00 K(+93.9%) | $728.00 K(+38.1%) |
June 2017 | - | $33.00 K(-126.4%) | $527.00 K(+54.1%) |
Mar 2017 | - | -$125.00 K(-116.5%) | $342.00 K(+15.9%) |
Dec 2016 | $295.00 K(+17.5%) | $756.00 K(-651.8%) | $295.00 K(-2207.1%) |
Sept 2016 | - | -$137.00 K(-9.9%) | -$14.00 K(-125.5%) |
June 2016 | - | -$152.00 K(-11.6%) | $55.00 K(-61.5%) |
Mar 2016 | - | -$172.00 K(-138.5%) | $143.00 K(-43.0%) |
Dec 2015 | $251.00 K(>+9900.0%) | $447.00 K(-757.4%) | $251.00 K(>+9900.0%) |
Sept 2015 | - | -$68.00 K(+6.3%) | $0.00(-100.0%) |
June 2015 | - | -$64.00 K(0.0%) | $9000.00(-43.8%) |
Mar 2015 | - | -$64.00 K(-132.7%) | $16.00 K(+700.0%) |
Dec 2014 | $2000.00(-99.0%) | $196.00 K(-432.2%) | $2000.00(-101.1%) |
Sept 2014 | - | -$59.00 K(+3.5%) | -$182.00 K(+38.9%) |
June 2014 | - | -$57.00 K(-26.9%) | -$131.00 K(-289.9%) |
Mar 2014 | - | -$78.00 K(-750.0%) | $69.00 K(-67.1%) |
Dec 2013 | $210.00 K(+162.5%) | $12.00 K(-250.0%) | $210.00 K(-14.6%) |
Sept 2013 | - | -$8000.00(-105.6%) | $246.00 K(-9.9%) |
June 2013 | - | $143.00 K(+127.0%) | $273.00 K(+93.6%) |
Mar 2013 | - | $63.00 K(+31.3%) | $141.00 K(+80.8%) |
Dec 2012 | $80.00 K(+81.8%) | $48.00 K(+152.6%) | $78.00 K(+160.0%) |
Sept 2012 | - | $19.00 K(+72.7%) | $30.00 K(+172.7%) |
June 2012 | - | $11.00 K | $11.00 K |
Dec 2011 | $44.00 K | - | - |
FAQ
- What is Arcturus Therapeutics Holdings annual interest expense?
- What is the all time high annual interest expense for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings annual interest expense year-on-year change?
- What is the all time high quarterly interest expense for Arcturus Therapeutics Holdings?
- What is the all time high TTM interest expense for Arcturus Therapeutics Holdings?
What is Arcturus Therapeutics Holdings annual interest expense?
The current annual interest expense of ARCT is $767.00 K
What is the all time high annual interest expense for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high annual interest expense is $3.00 M
What is Arcturus Therapeutics Holdings annual interest expense year-on-year change?
Over the past year, ARCT annual interest expense has changed by -$2.23 M (-74.44%)
What is the all time high quarterly interest expense for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high quarterly interest expense is $790.00 K
What is the all time high TTM interest expense for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high TTM interest expense is $3.03 M